{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:24:53Z","timestamp":1792272293747,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Quercetin (QUE) is a natural polyphenol known to have numerous pharmacological properties against infectious and non-infectious diseases. Azithromycin (AZ) is an antibiotic that belongs to the azalide class of antimicrobials and an antiparasitic that is known to be effective in combination with clindamycin against pyrimethamine\/sulfadiazine-resistant <jats:italic>Toxoplasma gondii<\/jats:italic> tachyzoites in clinical settings. Both compounds are known to target protein synthesis and have anti-inflammatory properties. However, little is known about QUE and AZ synergistic interaction against <jats:italic>T. gondii<\/jats:italic> growth. Here, we report for the first time the effects of the combination of QUE and AZ on <jats:italic>T. gondii<\/jats:italic> growth. The 50% inhibitory concentration (IC<jats:sub>50<\/jats:sub>) for QUE at 72\u00a0h of interaction was determined to be 0.50\u00a0\u00b5M, whereas AZ gave an IC<jats:sub>50<\/jats:sub> value of 0.66\u00a0\u00b5M at 72\u00a0h of interaction with parasites. Combination testing of QUE and AZ in a ratio of 2:1 (QUE:AZ) showed an IC<jats:sub>50<\/jats:sub> value of 0.081\u00a0\u00b5M. Interestingly, a fractional inhibitory index value of 0.28 was observed, indicating a strong synergy. QUE was also found to upregulate the generation of reactive oxygen species and cause dysfunction of the mitochondria membrane of both intracellular and extracellular <jats:italic>T. gondii<\/jats:italic> tachyzoites. Overall, the results indicate that QUE is a novel lead capable of synergizing with AZ for inhibiting <jats:italic>T. gondii<\/jats:italic> growth and may merit future investigation in vivo for possible combination drug development.<\/jats:p>\n                <jats:p><jats:bold>Graphical Abstract<\/jats:bold><\/jats:p>","DOI":"10.1186\/s13071-023-05849-3","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T13:01:42Z","timestamp":1691067702000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Quercetin inhibits Toxoplasma gondii tachyzoite proliferation and acts synergically with azithromycin"],"prefix":"10.1186","volume":"16","author":[{"given":"Daniel A.","family":"Abugri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandani V. T.","family":"Wijerathne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homa Nath","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Ayariga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Napier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boakai K.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,3]]},"reference":[{"key":"5849_CR1","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.ijpara.2009.04.003","volume":"39","author":"G Pappas","year":"2009","unstructured":"Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol. 2009;39:1385\u201394.","journal-title":"Int J Parasitol"},{"key":"5849_CR2","volume-title":"Toxoplasmosis of animals and humans","author":"JP Dubey","year":"2022","unstructured":"Dubey JP. Toxoplasmosis of animals and humans. Boca Raton: CRC Press; 2022."},{"key":"5849_CR3","doi-asserted-by":"publisher","first-page":"90203","DOI":"10.1371\/journal.pone.0090203","volume":"9","author":"J Flegr","year":"2014","unstructured":"Flegr J, Prandota J, Sovi\u010dkov\u00e1 M, Israili ZH. Toxoplasmosis\u2014a global threat correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PLoS ONE. 2014;9:90203.","journal-title":"PLoS ONE"},{"key":"5849_CR4","unstructured":"Centers for disease control prevention. Parasites-toxoplasmosis (Toxoplasma Infection): epidemiology and risk. 2022. https:\/\/www.cdc.gov\/parasites\/toxoplasmosis\/epi.html. Accessed 19 Aug 2022."},{"key":"5849_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s15010-017-1111-3","volume":"46","author":"A Rostami","year":"2018","unstructured":"Rostami A, Karanis P, Fallahi S. Advances in serological, imaging techniques and molecular diagnosis of Toxoplasma gondii infection. Infection. 2018;46:303\u201315.","journal-title":"Infection"},{"key":"5849_CR6","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1056\/NEJM199406303302604","volume":"330","author":"NG Guerina","year":"1994","unstructured":"Guerina NG, Hsu HW, Meissner HC, Maguire JH, Lynfield R, Stechenberg B, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma working group. N Engl J Med. 1994;330:1858\u201363.","journal-title":"N Engl J Med"},{"key":"5849_CR7","unstructured":"Kota AS, Shabbir N. 2021. Congenital toxoplasmosis. Accessed 24 July 2022."},{"key":"5849_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jogoh.2017.12.003","volume":"47","author":"S Fallahi","year":"2018","unstructured":"Fallahi S, Rostami A, Shiadeh MN, Behniafar H, Paktinat S. An updated literature review on maternal-fetal and reproductive disorders of Toxoplasma gondii infection. J Gynecol Obstet Hum Reprod. 2018;47:133\u201340.","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"5849_CR9","volume-title":"Toxoplasma gondii: the model apicomplexan. Perspectives and methods","author":"LM Weiss","year":"2022","unstructured":"Weiss LM, Kim K. Toxoplasma gondii: the model apicomplexan. Perspectives and methods. New York: Elsevier; 2022."},{"key":"5849_CR10","volume-title":"Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases","author":"JG Montoya","year":"2017","unstructured":"Montoya JG, Boothroyd JC, Kovacs JA. Toxoplasma gondii. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases. 8th ed. Philadelphia: Churchill Livingstone Elsevier; 2017.","edition":"8"},{"key":"5849_CR11","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.3389\/fmicb.2018.02587","volume":"9","author":"M Montazeri","year":"2018","unstructured":"Montazeri M, Mehrzadi S, Sharif M, Sarvi S, Tanzifi A, Aghayan SA, Daryani A. Drug resistance in Toxoplasma gondii. Front Microbiol. 2018;9:2587.","journal-title":"Front Microbiol"},{"key":"5849_CR12","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1056\/NEJM199212033272306","volume":"327","author":"SB Porter","year":"1992","unstructured":"Porter SB, Sande MA. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med. 1992;327:1643\u20138.","journal-title":"N Engl J Med"},{"key":"5849_CR13","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1179\/2047773213Y.0000000094","volume":"107","author":"S Rajapakse","year":"2013","unstructured":"Rajapakse S, Chrishan Shivanthan M, Samaranayake N, Rodrigo C, Deepika FS. Antibiotics for human toxoplasmosis: a systematic review of randomized trials. Pathog Glob Health. 2013;107:162\u20139.","journal-title":"Pathog Glob Health"},{"key":"5849_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.actatropica.2011.10.018","volume":"121","author":"Y Carlier","year":"2012","unstructured":"Carlier Y, Truyens C, Deloron P, Peyron F. Congenital parasitic infections: a review. Acta Trop. 2012;121:55\u201370.","journal-title":"Acta Trop"},{"key":"5849_CR15","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s40268-017-0206-8","volume":"17","author":"RR Ben-Harari","year":"2017","unstructured":"Ben-Harari RR, Goodwin E, Casoy J. Adverse event profile of pyrimethamine-based therapy in toxoplasmosis: a systematic review. Drugs R D. 2017;17:523\u201344.","journal-title":"Drugs R D"},{"key":"5849_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-80569-7","volume":"11","author":"AM Shammaa","year":"2021","unstructured":"Shammaa AM, Powell TG, Benmerzouga I. Adverse outcomes associated with the treatment of Toxoplasma infections. Sci Rep. 2021;11:1\u20138.","journal-title":"Sci Rep"},{"key":"5849_CR17","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.3390\/molecules25071574","volume":"25","author":"A Secrieru","year":"2020","unstructured":"Secrieru A, Costa IC, O\u2019Neill PM, Cristiano ML. Antimalarial agents as therapeutic tools against toxoplasmosis\u2014a short bridge between two distant illnesses. Molecules. 2020;25:1574.","journal-title":"Molecules"},{"key":"5849_CR18","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3201\/eid2504.181689","volume":"25","author":"D Shiojiri","year":"2019","unstructured":"Shiojiri D, Kinai E, Teruya K, Kikuchi Y, Oka S. Combination of clindamycin and azithromycin as alternative treatment for Toxoplasma gondii Encephalitis. Emerg Infect Dis. 2019;25:84.","journal-title":"Emerg Infect Dis"},{"key":"5849_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-12-132","volume":"12","author":"LS Castro-Filice","year":"2014","unstructured":"Castro-Filice LS, Barbosa BF, Angeloni MB, Silva NM, Gomes AO, Alves CMOS, Silva DAO, et al. Azithromycin is able to control Toxoplasma gondii infection in human villous explants. J Trans Med. 2014;12:1\u201312.","journal-title":"J Trans Med"},{"key":"5849_CR20","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.freeradbiomed.2011.04.032","volume":"51","author":"SB Lotito","year":"2011","unstructured":"Lotito SB, Zhang W, Yang CS, Crozier A, Frei B. Metabolic conversion of dietary flavonoids alters their anti-inflammatory and antioxidant properties. Free Radical Biol Med. 2011;51:454\u201363.","journal-title":"Free Radical Biol Med"},{"key":"5849_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00289-022-04091-8","volume":"80","author":"M Azeem","year":"2023","unstructured":"Azeem M, Hanif M, Mahmood K, Ameer N, Chughtai FRS, Abid U. An insight into anticancer, antioxidant, antimicrobial, antidiabetic and anti-inflammatory effects of quercetin: a review. Polymer Bull. 2023;80:241\u201362.","journal-title":"Polymer Bull"},{"key":"5849_CR22","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.foodchem.2012.01.060","volume":"133","author":"Y Chang","year":"2012","unstructured":"Chang Y, Lin H, Chan S, Yeh S. Effects of quercetin metabolites on the enhancing effect of b-carotene on DNA damage and cytochrome P1A1\/2 expression in benzo [a] pyrene-exposed A549 cells. Food Chem. 2012;133:445\u201350.","journal-title":"Food Chem"},{"key":"5849_CR23","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1002\/jcb.21958","volume":"105","author":"JY Kim","year":"2008","unstructured":"Kim JY, Kim EH, Park SS, Lim JH, Kwon TK, et al. Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 upregulation and proteasome-mediated c-FLIPS down-regulation. J Cell Biochem. 2008;105:1386\u201398.","journal-title":"J Cell Biochem"},{"key":"5849_CR24","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.nut.2010.09.002","volume":"27","author":"S Yoshino","year":"2011","unstructured":"Yoshino S, Hara A, Sakakibara H, Kawabata K, Tokumura A, et al. Effect of quercetin and glucuronide metabolites on the monoamine oxidase-A reaction in mouse brain mitochondria. Nutrition. 2011;27:847\u201352.","journal-title":"Nutrition"},{"key":"5849_CR25","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.freeradbiomed.2017.05.003","volume":"108","author":"Y Xue","year":"2017","unstructured":"Xue Y, Du M, Zhu MJ. Quercetin suppresses NLRP3 inflammasome activation in epithelial cells triggered by Escherichia coli O157:H7. Free Radic Biol Med. 2017;108:760\u20139.","journal-title":"Free Radic Biol Med"},{"key":"5849_CR26","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1254\/jphs.10R38FM","volume":"115","author":"K Ishizawa","year":"2011","unstructured":"Ishizawa K, Yoshizumi M, Kawai Y, Terao J, Kihira Y, Ikeda Y, et al. Pharmacology in health food: metabolism of quercetin in vivo and its protective effect against arteriosclerosis. J Pharmacol Sci. 2011;115:466\u201370.","journal-title":"J Pharmacol Sci"},{"key":"5849_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40360-016-0083-8","volume":"17","author":"S Siriwong","year":"2016","unstructured":"Siriwong S, Teethaisong Y, Thumanu K, Dunkhunthod B, Eumkeb G. The synergy and mode of action of quercetin plus amoxicillin against amoxicillin-resistant Staphylococcus epidermidis. BMC Pharmacol Toxicol. 2016;17:1\u201314.","journal-title":"BMC Pharmacol Toxicol"},{"key":"5849_CR28","doi-asserted-by":"publisher","first-page":"e0241304","DOI":"10.1371\/journal.pone.0241304","volume":"15","author":"C Vipin","year":"2020","unstructured":"Vipin C, Saptami K, Fida F, Mujeeburahiman M, Rao SS, Arun AB, et al. Potential synergistic activity of quercetin with antibiotics against multidrug-resistant clinical strains of Pseudomonas aeruginosa. PLoS ONE. 2020;15:e0241304.","journal-title":"PLoS ONE"},{"key":"5849_CR29","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1021\/acs.jnatprod.8b00356","volume":"81","author":"YS Emiliano","year":"2018","unstructured":"Emiliano YS, Almeida-Amaral EE. Efficacy of apigenin and miltefosine combination therapy against experimental cutaneous leishmaniasis. J Nat Prod. 2018;81:1910\u20133.","journal-title":"J Nat Prod"},{"key":"5849_CR30","doi-asserted-by":"publisher","first-page":"852889","DOI":"10.3389\/fcimb.2022.852889","volume":"12","author":"AM Huffman","year":"2022","unstructured":"Huffman AM, Ayariga JA, Napier A, Robertson BK, Abugri DA. Inhibition of Toxoplasma gondii growth by dihydroquinine and its mechanisms of action. Front Cell Infect Microbiol. 2022;12:852889. https:\/\/doi.org\/10.3389\/fcimb.2022.852889.","journal-title":"Front Cell Infect Microbiol"},{"key":"5849_CR31","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1128\/AAC.37.8.1701","volume":"37","author":"J Blais","year":"1993","unstructured":"Blais J, Garneau V, Chamberland S. Inhibition of Toxoplasma gondii protein synthesis by azithromycin. Antimicrob Agents Chemother. 1993;37:1701\u20133.","journal-title":"Antimicrob Agents Chemother"},{"key":"5849_CR32","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/cbdd.13070","volume":"91","author":"DA Abugri","year":"2018","unstructured":"Abugri DA, Witola WH, Russell AE, Troy RM. In vitro activity of the interaction between taxifolin (dihydroquercetin) and pyrimethamine against Toxoplasma gondii. Chem Biol Drug Des. 2018;91:194\u2013201.","journal-title":"Chem Biol Drug Des"},{"key":"5849_CR33","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s12639-019-01185-5","volume":"44","author":"DA Abugri","year":"2020","unstructured":"Abugri DA, Witola WH. Interaction of apigenin-7-O-glucoside with pyrimethamine against Toxoplasma gondii growth. J Parasit Dis. 2020;44:221\u20139.","journal-title":"J Parasit Dis"},{"key":"5849_CR34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fcimb.2021.618994","volume":"11","author":"CI Ma","year":"2021","unstructured":"Ma CI, Tirtorahardjo JA, Jan S, Schweizer SS, Rosario SA, Du Y, et al. Auranofin resistance in Toxoplasma gondii decreases the accumulation of reactive oxygen species but does not target parasite thioredoxin reductase. Front Cell Infect Microbiol. 2021;11:20. https:\/\/doi.org\/10.3389\/fcimb.2021.618994.","journal-title":"Front Cell Infect Microbiol"},{"key":"5849_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep22997","volume":"6","author":"RA Charvat","year":"2016","unstructured":"Charvat RA, Arrizabalaga G. Oxidative stress generated during monensin treatment contributes to altered Toxoplasma gondii mitochondrial function. Sci Rep. 2016;6:1\u201317.","journal-title":"Sci Rep"},{"key":"5849_CR36","doi-asserted-by":"publisher","first-page":"8667","DOI":"10.1038\/s41598-023-35676-6","volume":"13","author":"HN Sharma","year":"2023","unstructured":"Sharma HN, Catrett J, Nwokeocha OD, Boersma M, Miller ME, Napier A, et al. Anti-Toxoplasma gondii activity of Trametes versicolor (Turkey tail) mushroom extract. Sci Rep. 2023;13:8667.","journal-title":"Sci Rep"},{"key":"5849_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijpddr.2018.12.004","volume":"9","author":"JL Zhang","year":"2019","unstructured":"Zhang JL, Si HF, Shang XF, Zhang XK, Li B, Zhou XZ, et al. New life for an old drug: in vitro and in vivo effects of the anthelmintic drug niclosamide against Toxoplasma gondii RH strain. Int J Parasitol Drugs Drug Resist. 2019;9:27\u201334.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"5849_CR38","doi-asserted-by":"publisher","first-page":"684393","DOI":"10.3389\/fcell.2021.684393","volume":"9","author":"J Zhang","year":"2021","unstructured":"Zhang J, Si H, Lv K, Qiu Y, Sun J, Bai Y, et al. Licarin-B exhibits activity against the Toxoplasma gondii RH strain by damaging mitochondria and activating autophagy. Front Cell Dev Biol. 2021;9:684393.","journal-title":"Front Cell Dev Biol"},{"key":"5849_CR39","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.3389\/fmicb.2019.02152","volume":"10","author":"J Zhang","year":"2019","unstructured":"Zhang J, Si H, Li B, Zhou X, Zhang J. Myrislignan exhibits activities against Toxoplasma gondii RH strain by triggering mitochondrial dysfunction. Front Microbiol. 2019;10:2152. https:\/\/doi.org\/10.3389\/fmicb.2019.02152.","journal-title":"Front Microbiol"},{"key":"5849_CR40","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3389\/fcimb.2017.00512","volume":"7","author":"G Syn","year":"2017","unstructured":"Syn G, Anderson D, Blackwell JM, Jamieson SE. Toxoplasma Gondii infection is associated with mitochondrial dysfunction in-Vitro. Front Cell Infection Microbiol. 2017;7:512. https:\/\/doi.org\/10.3389\/fcimb.2017.00512.","journal-title":"Front Cell Infection Microbiol"},{"issue":"2","key":"5849_CR41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/AAC.01640-17","volume":"62","author":"J Spalenka","year":"2018","unstructured":"Spalenka J, Escotte-Binet S, Bakiri A, Hubert J, Renault J-H, Velard F, Duchateau S, Aubert D, Huguenin A, Villena I. Discovery of new inhibitors of Toxoplasma gondii via the pathogen box. Antimicrob Agents Chemother. 2018;62(2):10\u20131128.","journal-title":"Antimicrob Agents Chemother"},{"key":"5849_CR42","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.parint.2017.10.010","volume":"67","author":"AG Sanford","year":"2018","unstructured":"Sanford AG, Schulze TT, Potluri LP, Hemsley RM, Larson JJ, Judge AK, et al. Novel Toxoplasma gondii inhibitor chemotypes. Parasitol Int. 2018;67:107\u201311.","journal-title":"Parasitol Int"},{"key":"5849_CR43","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/jac\/38.1.75","volume":"38","author":"AJ van der Ven","year":"1996","unstructured":"van der Ven AJ, Schoondermark-van de Ven EM, Camps W, Melchers WJ, Koopmans PP, van der Meer JW, et al. Anti-toxoplasma effect of pyrimethamine, trimethoprim and sulphonamides alone and in combination: implications for therapy. J Antimicrob Chemother. 1996;38:75\u201380.","journal-title":"J Antimicrob Chemother"},{"key":"5849_CR44","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1128\/AAC.33.10.1753","volume":"33","author":"F Derouin","year":"1989","unstructured":"Derouin F, Chastang C. In vitro effects of folate inhibitors on Toxoplasma gondii. Antimicrob Agents Chemother. 1989;33:1753\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"5849_CR45","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1128\/AAC.01825-12","volume":"57","author":"CD Goodman","year":"2013","unstructured":"Goodman CD, Useglio M, Peir\u00fa S, Labadie GR, McFadden GI, Rodr\u00edguez E, et al. Chemobiosynthesis of new antimalarial macrolides. Antimicrob Agents Chemother. 2013;57:907\u201313.","journal-title":"Antimicrob Agents Chemother"},{"key":"5849_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12915-015-0162-0","volume":"13","author":"DW Wilson","year":"2015","unstructured":"Wilson DW, Goodman CD, Sleebs BE, Weiss GE, de Jong NW, Angrisano F, et al. Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite Plasmodium falciparum. BMC Biol. 2015;13:1\u201319.","journal-title":"BMC Biol"},{"issue":"15","key":"5849_CR47","first-page":"4317","volume":"54","author":"Y Liu","year":"2013","unstructured":"Liu Y, Kam W, Ding J, Sullivan D. Impact of azithromycin on lipid accumulation in immortalized human meibomian gland epithelial cells. Invest Ophthalmol Vis Sci. 2013;54(15):4317\u20134317.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"5849_CR48","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.chemphyslip.2006.08.002","volume":"144","author":"N Fa","year":"2006","unstructured":"Fa N, Ronkart S, Schanck A, Deleu M, Gaigneaux A, Goormaghtigh E, Mingeot-Leclercq M-P. Effect of the antibiotic azithromycin on thermotropic behavior of DOPC or DPPC bilayers. Chem Phys lipids. 2006;144(1):108\u201316.","journal-title":"Chem Phys lipids"},{"issue":"Suppl C","key":"5849_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/37.suppl_C.1","volume":"37","author":"H Lode","year":"1996","unstructured":"Lode H, Borner K, Koeppe P, Schaberg T. Azithromycin\u2014review of key chemical, pharmacokinetic and microbiological features. J Antimicrobial Chemother. 1996;37(Suppl C):1\u20138.","journal-title":"J Antimicrobial Chemother"},{"key":"5849_CR50","doi-asserted-by":"publisher","first-page":"e14666","DOI":"10.1371\/journal.pone.0014666","volume":"6","author":"F Fonseca-Silva","year":"2011","unstructured":"Fonseca-Silva F, Inacio JD, Canto-Cavalheiro MM, Almeida-Amaral EE. Reactive oxygen species production and mitochondrial dysfunction contribute to quercetin induced death in Leishmania amazonensis. PLoS ONE. 2011;6:e14666.","journal-title":"PLoS ONE"},{"issue":"12","key":"5849_CR51","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.phymed.2014.08.004","volume":"21","author":"I Sifaoui","year":"2014","unstructured":"Sifaoui I, Lopez-Arencibia A, Mart\u00edn-Navarro CM, Ticona JC, Reyes-Batlle M, Mejri M, et al. In vitro effects of triterpenic acids from olive leaf extracts on the mitochondrial membrane potential of promastigote stage of Leishmania spp. Phytomedicine 2014;21(12):1689\u20131694.","journal-title":"Phytomedicine"},{"key":"5849_CR52","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fenvs.2014.00053","volume":"2","author":"K Das","year":"2014","unstructured":"Das K, Roychoudhury A. Reactive oxygen species (ROS) and response of antioxidants as ROS-scavengers during environmental stress in plants. Front Environ Sci. 2014;2:53.","journal-title":"Front Environ Sci"},{"key":"5849_CR53","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s10495-008-0224-7","volume":"13","author":"R Das","year":"2008","unstructured":"Das R, Roy A, Dutta N, Majumder HK. Reactive oxygen species and imbalance of calcium homeostasis contributes to curcumin induced programmed cell death in Leishmania donovani. Apoptosis. 2008;13:867\u201382.","journal-title":"Apoptosis"},{"key":"5849_CR54","doi-asserted-by":"publisher","first-page":"11849","DOI":"10.1021\/acsomega.0c01818","volume":"5","author":"B Salehi","year":"2020","unstructured":"Salehi B, Machin L, Monzote L, Sharifi-Rad J, Ezzat SM, Salem MA, et al. Therapeutic potential of quercetin: new insights and perspectives for human health. ACS Omega. 2020;5:11849\u201372.","journal-title":"ACS Omega"},{"key":"5849_CR55","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jep.2012.07.005","volume":"143","author":"F Dajas","year":"2012","unstructured":"Dajas F. Life or death: neuroprotective and anticancer effects of quercetin. J Ethnopharmacol. 2012;143:383\u201396.","journal-title":"J Ethnopharmacol"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-023-05849-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-023-05849-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-023-05849-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T15:06:12Z","timestamp":1710515172000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-023-05849-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,3]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5849"],"URL":"https:\/\/doi.org\/10.1186\/s13071-023-05849-3","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,3]]},"assertion":[{"value":"9 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study does not involve any vertebrate animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agreed on the content of the paper for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There is no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"261"}}